1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
2
|
Cheng W, Zhang Z and Wang J: Long
noncoding RNAs: New players in prostate cancer. Cancer Lett.
339:8–14. 2013. View Article : Google Scholar : PubMed/NCBI
|
3
|
Hawksworth D, Ravindranath L, Chen Y,
Furusato B, Sesterhenn IA, McLeod DG, Srivastava S and Petrovics G:
Overexpression of C-MYC oncogene in prostate cancer predicts
biochemical recurrence. Prostate Cancer Prostatic Dis. 13:311–315.
2010. View Article : Google Scholar : PubMed/NCBI
|
4
|
Prensner JR, Chen W, Han S, Iyer MK, Cao
Q, Kothari V, Evans JR, Knudsen KE, Paulsen MT, Ljungman M, et al:
The long non-coding RNA PCAT-1 promotes prostate cancer cell
proliferation through cMyc. Neoplasia. 16:900–908. 2014. View Article : Google Scholar : PubMed/NCBI
|
5
|
Chang C, Liu J, He W, Qu M, Huang X, Deng
Y, Shen L, Zhao X, Guo H, Jiang J, et al: A regulatory circuit
HP1gamma/miR-451a/c-Myc promotes prostate cancer progression.
Oncogene. 37:415–426. 2018. View Article : Google Scholar : PubMed/NCBI
|
6
|
Zhang C, Wang L, Wang X and Gao S: The
mystery of ‘junk’ DNA. Chin Sci Bull. 61:3079–3084. 2016.
|
7
|
Adams BD, Anastasiadou E, Esteller M, He L
and Slack FJ: The Inescapable Influence of Noncoding RNAs in
Cancer. Cancer Res. 75:5206–5210. 2015. View Article : Google Scholar : PubMed/NCBI
|
8
|
Schwarzer A, Emmrich S, Schmidt F, Beck D,
Ng M, Reimer C, Adams FF, Grasedieck S, Witte D, Käbler S, et al:
The non-coding RNA landscape of human hematopoiesis and leukemia.
Nat Commun. 8:218–234. 2017. View Article : Google Scholar : PubMed/NCBI
|
9
|
Merola R, Tomao L, Antenucci A, Sperduti
I, Sentinelli S, Masi S, Mandoj C, Orlandi G, Papalia R, et al:
PCA3 in prostate cancer and tumor aggressiveness detection on 407
high-risk patients: a National Cancer Institute experience. J Exp
Clin Cancer Res. 34:15–20. 2015. View Article : Google Scholar : PubMed/NCBI
|
10
|
Prensner JR, Iyer MK, Sahu A, Asangani IA,
Cao Q, Patel L, Vergara IA, Davicioni E, Erho N, Ghadessi M, et al:
The long noncoding RNA SChLAP1 promotes aggressive prostate cancer
and antagonizes the SWI/SNF complex. Nat Genet. 45:1392–1398. 2013.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Parolia A, Crea F, Xue H, Wang Y, Mo F,
Ramnarine VR, Liu HH, Lin D, Saidy NR, Clermont PL, et al: The long
non-coding RNA PCGEM1 is regulated by androgen receptor activity in
vivo. Mol Cancer. 14:46–52. 2015. View Article : Google Scholar : PubMed/NCBI
|
12
|
Liu XH, Sun M, Nie FQ, Ge YB, Zhang EB,
Yin DD, Kong R, Xia R, Lu KH, Li JH, et al: Lnc RNA HOTAIR
functions as a competing endogenous RNA to regulate HER2 expression
by sponging miR-331-3p in gastric cancer. Mol Cancer. 13:92–105.
2014. View Article : Google Scholar : PubMed/NCBI
|
13
|
Fang C, Qiu S, Sun F, Li W, Wang Z, Yue B,
Wu X and Yan D: Long non-coding RNA HNF1A-AS1 mediated repression
of miR-34a/SIRT1/p53 feedback loop promotes the metastatic
progression of colon cancer by functioning as a competing
endogenous RNA. Cancer Lett. 410:50–62. 2017. View Article : Google Scholar : PubMed/NCBI
|
14
|
Kawasaki Y, Komiya M, Matsumura K, Negishi
L, Suda S, Okuno M, Yokota N, Osada T, Nagashima T, Hiyoshi M, et
al: MYU, a target lncRNA for Wnt/c-Myc signaling, mediates
induction of CDK6 to promote cell cycle progression. Cell Reports.
16:2554–2564. 2016. View Article : Google Scholar : PubMed/NCBI
|
15
|
Yang L, Xu L, Wang Q, Wang M and An G:
Dysregulation of long non-coding RNA profiles in human colorectal
cancer and its association with overall survival. Oncol Lett.
12:4068–4074. 2016. View Article : Google Scholar : PubMed/NCBI
|
16
|
Chen M, Wu X, Ma W, Zhou Q, Wang X, Zhang
R, Wang J and Yang X: Decreased expression of lncRNA VPS9D1-AS1 in
gastric cancer and its clinical significance. Cancer Biomark.
21:23–28. 2017. View Article : Google Scholar : PubMed/NCBI
|
17
|
Weinstein JN, Collisson EA, Mills GB, Shaw
KR, Ozenberger BA, Ellrott K, Shmulevich I, Sander C and Stuart JM:
Cancer Genome Atlas Research Network: The Cancer Genome Atlas
Pan-Cancer analysis project. Nat Genet. 45:1113–1120. 2013.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Iyer MK, Niknafs YS, Malik R, Singhal U,
Sahu A, Hosono Y, Barrette TR, Prensner JR, Evans JR, Zhao S, et
al: The landscape of long noncoding RNAs in the human
transcriptome. Nat Genet. 47:199–208. 2015. View Article : Google Scholar : PubMed/NCBI
|
19
|
Cheng PF, Dummer R and Levesque MP: Data
mining The Cancer Genome Atlas in the era of precision cancer
medicine. Swiss Med Wkly. 145:w141832015.PubMed/NCBI
|
20
|
Zhang Y, Liu T, Meyer CA, Eeckhoute J,
Johnson DS, Bernstein BE, Nusbaum C, Myers RM, Brown M, Li W, et
al: Model-based analysis of ChIP-Seq (MACS). Genome Biol.
9:R1372008. View Article : Google Scholar : PubMed/NCBI
|
21
|
Feng J, Liu T and Zhang Y: Using MACS to
identify peaks from ChIP-Seq data. Curr Protoc Bioinformatics
Chapter. 2:Unit2.14. 2011.
|
22
|
Kent WJ, Sugnet CW, Furey TS, Roskin KM,
Pringle TH, Zahler AM and Haussler D: The human genome browser at
UCSC. Genome Res. 12:996–1006. 2002. View Article : Google Scholar : PubMed/NCBI
|
23
|
Liang G and Weisenberger DJ: DNA
methylation aberrancies as a guide for surveillance and treatment
of human cancers. Epigenetics. 12:416–432. 2017. View Article : Google Scholar : PubMed/NCBI
|
24
|
Creyghton MP, Cheng AW, Welstead GG,
Kooistra T, Carey BW, Steine EJ, Hanna J, Lodato MA, Frampton GM,
Sharp PA, et al: Histone H3K27ac separates active from poised
enhancers and predicts developmental state. Proc Natl Acad Sci USA.
107:21931–21936. 2010. View Article : Google Scholar : PubMed/NCBI
|
25
|
Liu X, Wang C, Liu W, Li J, Li C, Kou X,
Chen J, Zhao Y, Gao H, Wang H, et al: Distinct features of H3K4me3
and H3K27me3 chromatin domains in pre-implantation embryos. Nature.
537:558–562. 2016. View Article : Google Scholar : PubMed/NCBI
|
26
|
Pokholok DK, Harbison CT, Levine S, Cole
M, Hannett NM, Lee TI, Bell GW, Walker K, Rolfe PA, Herbolsheimer
E, et al: Genome-wide map of nucleosome acetylation and methylation
in yeast. Cell. 122:517–527. 2005. View Article : Google Scholar : PubMed/NCBI
|
27
|
Huang B, Song JH, Cheng Y, Abraham JM,
Ibrahim S, Sun Z, Ke X and Meltzer SJ: Long non-coding antisense
RNA KRT7-AS is activated in gastric cancers and supports cancer
cell progression by increasing KRT7 expression. Oncogene.
35:4927–4936. 2016. View Article : Google Scholar : PubMed/NCBI
|
28
|
Sun J, Wang X, Fu C, Wang X, Zou J, Hua H
and Bi Z: Long noncoding RNA FGFR3-AS1 promotes osteosarcoma growth
through regulating its natural antisense transcript FGFR3. Mol Biol
Rep. 43:427–436. 2016. View Article : Google Scholar : PubMed/NCBI
|
29
|
Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ,
Tao QF, Liu F, Pan W, Wang TT, Zhou CC, et al: A long noncoding RNA
activated by TGF-β promotes the invasion-metastasis cascade in
hepatocellular carcinoma. Cancer Cell. 25:666–681. 2014. View Article : Google Scholar : PubMed/NCBI
|
30
|
Emdad L, Janjic A, Alzubi MA, Hu B,
Santhekadur PK, Menezes ME, Shen XN, Das SK, Sarkar D and Fisher
PB: Suppression of miR-184 in malignant gliomas upregulates SND1
and promotes tumor aggressiveness. Neuro-oncol. 17:419–429. 2015.
View Article : Google Scholar : PubMed/NCBI
|
31
|
Cheng Z, Wang HZ, Li X, Wu Z, Han Y, Li Y,
Chen G, Xie X, Huang Y, Du Z, et al: MicroRNA-184 inhibits cell
proliferation and invasion, and specifically targets TNFAIP2 in
Glioma. J Exp Clin Cancer Res. 34:272015. View Article : Google Scholar : PubMed/NCBI
|
32
|
Wang YB, Zhao XH, Li G, Zheng JH and Qiu
W: MicroRNA-184 inhibits proliferation and promotes apoptosis of
human colon cancer SW480 and HCT116 cells by downregulating C-MYC
and BCL-2. J Cell Biochem. 119:1702–1715. 2018. View Article : Google Scholar : PubMed/NCBI
|
33
|
Zhen Y, Liu Z, Yang H, Yu X, Wu Q, Hua S,
Long X, Jiang Q, Song Y, Cheng C, et al: Tumor suppressor PDCD4
modulates miR-184-mediated direct suppression of C-MYC and BCL2
blocking cell growth and survival in nasopharyngeal carcinoma. Cell
Death Dis. 4:e8722013. View Article : Google Scholar : PubMed/NCBI
|
34
|
Bhattacharjya S, Roy KS, Ganguly A, Sarkar
S, Panda CK, Bhattacharyya D, Bhattacharyya NP and Roychoudhury S:
Inhibition of nucleoporin member Nup214 expression by miR-133b
perturbs mitotic timing and leads to cell death. Mol Cancer.
14:42–56. 2015. View Article : Google Scholar : PubMed/NCBI
|
35
|
Qu L, Ding J, Chen C, Wu ZJ, Liu B, Gao Y,
Chen W, Liu F, Sun W, Li XF, et al: Exosome-transmitted lncARSR
promotes sunitinib resistance in renal cancer by acting as a
competing endogenous RNA. Cancer Cell. 29:653–668. 2016. View Article : Google Scholar : PubMed/NCBI
|
36
|
Gao Y, Huang KH, Tang Y, Huang Y and Gao
S: Exosome: A rising star in the era of precision oncology. Chin
Sci Bull. 63:1–8. 2018.
|
37
|
He W, Zhong G, Jiang N, Wang B, Fan X,
Chen C, Chen X, Huang J and Lin T: Long noncoding RNA BLACAT2
promotes bladder cancer-associated lymphangiogenesis and lymphatic
metastasis. J Clin Invest. 128:861–875. 2018. View Article : Google Scholar : PubMed/NCBI
|
38
|
Marín-Béjar O, Mas AM, González J,
Martinez D, Athie A, Morales X, Galduroz M, Raimondi I, Grossi E,
Guo S, et al: The human lncRNA LINC-PINT inhibits tumor cell
invasion through a highly conserved sequence element. Genome Biol.
18:202–216. 2017. View Article : Google Scholar : PubMed/NCBI
|
39
|
Théry C: Exosomes: Secreted vesicles and
intercellular communications. F1000 Biol Rep. 3:15–22. 2011.
View Article : Google Scholar : PubMed/NCBI
|
40
|
Melo SA, Sugimoto H, O'Connell JT, Kato N,
Villanueva A, Vidal A, Qiu L, Vitkin E, Perelman LT, Melo CA, et
al: Cancer exosomes perform cell-independent microRNA biogenesis
and promote tumorigenesis. Cancer Cell. 26:707–721. 2014.
View Article : Google Scholar : PubMed/NCBI
|
41
|
Huang X, Yuan T, Liang M, Du M, Xia S,
Dittmar R, Wang D, See W, Costello BA, Quevedo F, et al: Exosomal
miR-1290 and miR-375 as prognostic markers in castration-resistant
prostate cancer. Eur Urol. 67:33–41. 2015. View Article : Google Scholar : PubMed/NCBI
|